About Timothy Cannon, MD
Dr. Timothy Cannon is Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova. He is a specialty care physician board certified in medical oncology. He has a special interest in management of gastrointestinal malignancies.
Dr. Cannon is the clinical director and moderator of the weekly molecular tumor board at Inova, which matches patients with targeted therapies based on molecular diagnostics. He is very interested in national cooperative group clinical trials and is a member of the NRG colorectal and non-colorectal clinical trials committee. He is the site principal investigator for multiple clinical trials in immunotherapy.
Dr. Cannon is chair-elect of the steering committee for the TAPUR trial, which is the largest oncology basket trial in North America. He also served as the chief fellow of hematology/oncology at New York University (NYU). Dr. Cannon was voted fellow of the year at NYU during each of his last two years there. He received a "best doctor" award by Northern Virginia magazine in 2015.
A native of New Jersey, Dr. Cannon is married with two sons. His wife, Amy, works for Save the Children. In his spare time, he likes to play sports (particularly soccer, flag football, tennis) and read books. He was a member of two Division I basketball teams (University of Utah as a freshman and then later at Brigham Young University) in the 1990s and continues to be a huge basketball fan.
- Assistant Professor, Department of Medicine, Virginia Commonwealth University
- NYU Chief Fellow of Hematology/Oncology 2010-2011
- NYU Fellow of the Year 2011
- NYU Fellow of the Year 2010
- American Society of Clinical Oncology
- Top Doctors, Washingtonian, 2020, 2022
Research and Publications
View list of publications from Dr. Cannon's research
Endurance Sports and Colorectal Cancer: Is There a Connection? (October 2022)
Immunotherapy: Cancer Care Gets Customized (October 2017)
Colon Cancer in Young Adults: Know Your Risk (April 2017)
David Bowie and Liver Cancer: Bringing Awareness to the Disease and Promising New Treatments on the Horizon (January 2016)
Why Us and not the Elephants? (November 2015)
Supplements: Proceed with Caution (August 2015)
Pharmacogenomics: Personalized Medicine in Action (August 2015)
Drugs blocking tumor proteins offer hope for cancer outcomes (June 2015)
Medical EducationRutgers Medical School 2005
Training Specialty: Internal Medicine
6/23/2005 - 6/30/2008
Training Specialty: Hematology/Oncology
7/1/2008 - 7/1/2011
About Patient Comments
The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.